Avanos Medical Inc. (AVNS)
NYSE: AVNS
· Real-Time Price · USD
11.20
0.24 (2.19%)
At close: Aug 15, 2025, 3:46 PM
Avanos Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 175M | 167.5M | 179.6M | 170.4M | 171.7M | 166.1M | 173.3M | 171.3M | 169.4M | 191.7M | 217.5M | 202.1M | 203M | 197.4M | 193.4M | 184.1M | 186.4M | 180.7M |
Cost of Revenue | 82.9M | 77.7M | 81.6M | 77.5M | 76.1M | 71.3M | 75.9M | 75.8M | 71.6M | 87.2M | 100.6M | 92M | 88.1M | 90.2M | 96.5M | 93.7M | 100.7M | 89.4M |
Gross Profit | 92.1M | 89.8M | 98M | 92.9M | 95.6M | 94.8M | 97.4M | 95.5M | 97.8M | 104.5M | 116.9M | 110.1M | 114.9M | 107.2M | 96.9M | 90.4M | 85.7M | 91.3M |
Operating Income | -74.5M | 10.3M | -418.5M | 12M | 16.1M | 7.4M | 22.2M | 1.2M | -2.1M | 2.6M | 26.2M | 18.7M | 19M | 9.2M | 25M | 3.6M | -7.3M | -12.4M |
Interest Income | 600K | 1.5M | 800K | 700K | 3M | 600K | 1M | 900K | 500K | 500K | 700K | 300K | 200K | n/a | n/a | 200K | n/a | n/a |
Pretax Income | -75.9M | 9.7M | -420.5M | 9.5M | 6.2M | 1.5M | 8.9M | -2.6M | -5.1M | -400K | 23.9M | 16M | 16.5M | 7.9M | 24.3M | 2.9M | -8.2M | -13.2M |
Net Income | -76.8M | 6.6M | -397.3M | 4.3M | 1.8M | -900K | 10.5M | -3.7M | -68.1M | -500K | 16.9M | 15.7M | 11.4M | 5.8M | 10M | -35.1M | 37.9M | -7.6M |
Selling & General & Admin | 75.7M | 75.7M | 79.7M | 74.3M | 73.2M | 80.4M | 68.4M | 78.7M | 93M | 92.7M | 82.6M | 82.1M | 87.1M | 90.1M | 75.2M | 75M | 76.7M | 73.4M |
Research & Development | 5.8M | 5.4M | 5.7M | 7.2M | 6.3M | 7M | 6.8M | 6.1M | 6.8M | 7.9M | 7.5M | 7.3M | 8M | 7.8M | 7.6M | 8.4M | 8M | 8.3M |
Other Expenses | n/a | n/a | 431.1M | n/a | n/a | n/a | n/a | n/a | n/a | 1.3M | 600K | 2M | 800K | 100K | -10.9M | 3.4M | 8.3M | 22M |
Operating Expenses | 81.5M | 79.5M | 516.5M | 80.9M | 79.5M | 87.4M | 75.2M | 94.3M | 99.9M | 101.9M | 90.7M | 91.4M | 95.9M | 98M | 71.9M | 86.8M | 93M | 103.7M |
Interest Expense | -6.2M | 2.1M | 2.8M | 3.2M | 3.1M | 3.1M | 3.3M | 4.7M | 3.5M | 3.5M | 3M | 3M | 2.7M | 1.3M | 700K | 900K | 900K | 800K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 164.4M | 157.2M | 598.1M | 153.7M | 155.6M | 158.7M | 151.1M | 170.1M | 171.5M | 189.1M | 191.3M | 183.4M | 184M | 188.2M | 168.4M | 180.5M | 193.7M | 193.1M |
Income Tax Expense | -7.1M | 3.1M | -23.5M | 3.6M | 1.9M | 1M | -2.1M | 6.2M | -800K | 100K | 7M | 300K | 5.1M | 2.1M | 14.3M | 38M | -46.1M | -5.6M |
Shares Outstanding (Basic) | 46.1M | 46.1M | 46M | 46M | 45.9M | 46.2M | 46.2M | 46.8M | 46.8M | 46.6M | 46.5M | 46.6M | 47.2M | 47.4M | 48.2M | 48.1M | 48.1M | 47.5M |
Shares Outstanding (Diluted) | 46.8M | 46.8M | 46M | 46.6M | 46.3M | 46.2M | 46.6M | 46.8M | 46.8M | 46.6M | 47M | 47M | 47.6M | 47.8M | 48.6M | 48.1M | 48.6M | 48M |
EPS (Basic) | -0.14 | 0.14 | -8.64 | 0.09 | 0.04 | -0.02 | 0.23 | -0.08 | -1.46 | -0.01 | 0.36 | 0.34 | 0.24 | 0.12 | 0.21 | -0.73 | 0.79 | -0.16 |
EPS (Diluted) | -0.14 | 0.14 | -8.64 | 0.09 | 0.04 | -0.02 | 0.23 | -0.08 | -1.46 | -0.01 | 0.36 | 0.33 | 0.24 | 0.12 | 0.21 | -0.73 | 0.78 | -0.16 |
EBITDA | -80.1M | 21.4M | -406.6M | 24.4M | 23M | 18.9M | 30.3M | 13.1M | 9.4M | 6M | 40.3M | 24.6M | 22.7M | 20.3M | 34.5M | 16.3M | 2.2M | -2.7M |
EBIT | n/a | 11.8M | -417.7M | 12.7M | 11.7M | 7.5M | 18.8M | 2.1M | -1.6M | -6.1M | 26.9M | 13.1M | 10.3M | 8.6M | 25M | 3.6M | -7.3M | -12.4M |
Depreciation & Amortization | 10M | 9.6M | 11.1M | 11.7M | 11.3M | 11.4M | 11.5M | 11M | 10.3M | 12.1M | 13.4M | 11.6M | 11.6M | 11.1M | 9.5M | 9.6M | 9.5M | 9.7M |